Stockreport

Vaxxinity Reports Fourth Quarter and Full-Year 2023 Financial Results and Provides Corporate Updates [Yahoo! Finance]

Vaxxinity, Inc.  (VAXX) 
PDF of immunotherapeutic vaccines, today reported financial results for the fourth quarter and full year ended December 31, 2023, and provided a corporate update. “2024 wi [Read more]